Pages that link to "Q35117398"
Jump to navigation
Jump to search
The following pages link to B7-H1 pathway and its role in the evasion of tumor immunity. (Q35117398):
Displaying 50 items.
- B7-H5 costimulates human T cells via CD28H (Q24295841) (← links)
- Ambivalent role of the innate immune response in rabies virus pathogenesis (Q24300579) (← links)
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target (Q24586342) (← links)
- Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma (Q24672476) (← links)
- The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta (Q24675388) (← links)
- Immunologic aspect of ovarian cancer and p53 as tumor antigen (Q24814703) (← links)
- Combining radiotherapy and cancer immunotherapy: a paradigm shift (Q27021428) (← links)
- Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy (Q27021570) (← links)
- Cancer immunotherapy (Q27026870) (← links)
- Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion (Q28281101) (← links)
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses (Q28504888) (← links)
- Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma (Q29620812) (← links)
- B7-H1 expression in vestibular schwannomas (Q30387475) (← links)
- B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells (Q33574520) (← links)
- Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma (Q33802505) (← links)
- Inhibitors of B7-CD28 costimulation in urologic malignancies (Q33827752) (← links)
- PD-1, gender, and autoimmunity (Q33910421) (← links)
- DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells (Q34001061) (← links)
- Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. (Q34056033) (← links)
- mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells (Q34097241) (← links)
- Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia (Q34245048) (← links)
- Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family (Q34271293) (← links)
- Use of tumour-responsive T cells as cancer treatment (Q34285656) (← links)
- The biology of human lymphoid malignancies revealed by gene expression profiling. (Q34313320) (← links)
- NFATc1 regulates PD-1 expression upon T cell activation. (Q34597324) (← links)
- PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. (Q34597843) (← links)
- B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells (Q35016870) (← links)
- The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. (Q35052176) (← links)
- Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer (Q35113261) (← links)
- Fusion protein of mutant B7-DC and Fc enhances the antitumor immune effect of GM-CSF-secreting whole-cell vaccine (Q35130450) (← links)
- B7-h1 expressed by activated CD8 T cells is essential for their survival. (Q35566744) (← links)
- Immunology of B7-H1 and its roles in human diseases (Q35611780) (← links)
- B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. (Q35630407) (← links)
- Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity (Q35762422) (← links)
- The roles of the new negative T cell costimulatory pathways in regulating autoimmunity (Q35772868) (← links)
- B7 molecule mRNA expression in colorectal carcinoma (Q35784085) (← links)
- DC-HIL is a negative regulator of T lymphocyte activation (Q35828672) (← links)
- Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma (Q35890860) (← links)
- Inhibitory costimulation and anti-tumor immunity (Q36016292) (← links)
- Immunotherapy for pancreatic cancer - science driving clinical progress (Q36133140) (← links)
- T cell tolerance induced by therapeutic antibodies (Q36251293) (← links)
- The many sounds of T lymphocyte silence. (Q36290302) (← links)
- Immunoregulatory role of B7-H1 in chronicity of inflammatory responses (Q36558794) (← links)
- Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue. (Q36639470) (← links)
- Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells? (Q36690273) (← links)
- Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3 CD4 regulatory T cells (Q36742588) (← links)
- Structures of PD-1 with its ligands: sideways and dancing cheek to cheek (Q36802593) (← links)
- Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion (Q36883024) (← links)
- Endogenous tumor-reactive CD8( ) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth. (Q37028003) (← links)
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication (Q37055402) (← links)